Schedule 13G ownership disclosure

ETERNA THERAPEUTICS INC

Security class unavailable · CUSIP: 114082209

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-004707
Form type
SC 13G/A
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jan 19, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub